Thompson Street buys LifeSpan Biosciences

Thompson Street Capital Partners said Sept. 17 that has acquired LifeSpan Biosciences Inc. Management is also investing. Financial terms weren’t announced. LifeSpan Biosciences, of Seattle, distributes antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. BroadOak Capital Partners served as LifeSpan Biosciences’ exclusive financial adviser. Achelous Partners acted as Thompson Street’s financial adviser.

DealsNorth AmericaUSBriefs